AETHLON MEDICAL, INC. (AEMD) Operating cash flow 2017–2026
AETHLON MEDICAL, INC. (AEMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.0MFY2026 · since FY2017: -$3.5M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$7.0M | +8.5% |
| FY2025 | -$7.6M | +24.5% |
| FY2024 | -$10.1M | +3.6% |
| FY2023 | -$10.5M | -7.6% |
| FY2022 | -$9.8M | -44.4% |
| FY2021 | -$6.8M | -30.2% |
| FY2020 | -$5.2M | -21.1% |
| FY2019 | -$4.3M | -9.8% |
| FY2018 | -$3.9M | -11.5% |
| FY2017 | -$3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AEMD financial trends
AEMD RevenueAEMD Net incomeAEMD Net marginAEMD Gross profitAEMD Gross marginAEMD Operating incomeAEMD Operating marginAEMD Free cash flowAEMD Capital expendituresAEMD Return on equityAEMD Stock buybacksAEMD Dividends paidAEMD Total assetsAEMD Total liabilitiesAEMD Shareholders’ equityAEMD overview →